Target intelligence / Profile preview

Selectin E and Selectin P (SELE and SELP)

Target
SELE and SELP
Molecular classification
Cell adhesion molecule, C-type lectin, Selectin family, Receptor
01

Overview

Selectin E (E-selectin) and Selectin P (P-selectin) are vital cell adhesion molecules expressed on the surface of activated vascular endothelial cells. They belong to the C-type lectin family and are primary mediators of the initial rolling phase of leukocyte recruitment to sites of inflammation and injury (UniProt P16581, P16109). P-selectin is rapidly mobilized from intracellular stores known as Weibel-Palade bodies upon stimulation, whereas E-selectin expression is induced over several hours by pro-inflammatory cytokines like TNF-alpha (StatPearls, Selectins). These proteins bind to carbohydrate ligands, such as Sialyl Lewis X on P-selectin glycoprotein ligand-1 (PSGL-1), facilitating the tethering of neutrophils and monocytes to the vessel wall. Dysregulation of this process is central to the pathogenesis of various conditions, including sickle cell disease vaso-occlusive crises and chronic inflammatory disorders (PubMed: 31722151). Additionally, selectins are exploited by certain cancer cells to facilitate metastasis through the bloodstream. Pharmacological inhibition of these targets, such as with the monoclonal antibody crizanlizumab, aims to disrupt these adhesive interactions to prevent vascular occlusion and reduce tissue damage (FDA, Adakveo).

Other names
E-selectinP-selectinCD62ECD62PEndothelial-leukocyte adhesion molecule 1 (ELAM-1)Granule membrane protein 140 (GMP-140)Platelet activation dependent granule-external membrane protein (PADGEM)Leukocyte-endothelial cell adhesion molecule 2 (LECAM2)
02

Mechanism of action

Selectin antagonism; inhibition of leukocyte-endothelial adhesion; blockade of the N-terminal lectin domain to prevent binding with sialylated carbohydrate ligands such as Sialyl Lewis X and PSGL-1.

03

Biological functions

Leukocyte rollingCell-cell adhesionImmune responseInflammatory responseHemostasisLeukocyte tethering
04

Disease associations

Sickle cell diseaseVaso-occlusive crisisInflammationCancer metastasisThrombosisAtherosclerosisIschemia-reperfusion injury
05

Safety considerations

Increased susceptibility to infectionInfusion-related reactionsPotential interference with normal leukocyte traffickingDelayed wound healing
06

Interacting drugs

Crizanlizumab

3 more in the full profile.

07

Biomarkers

Soluble E-selectin (sE-selectin)Soluble P-selectin (sP-selectin)P-selectin glycoprotein ligand-1 (PSGL-1) expression

Beyond the preview

Go deeper on Selectin E and Selectin P (SELE and SELP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selectin E and Selectin P (SELE and SELP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call